NCT00100347 - Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

July 31, 2007

Conditions

Non-Hodgkin's Lymphoma,Solid Tumors

Interventions

DRUG

PPI-2458

Trial Locations (8)

Columbia University Medical Center, New York

Universtiy of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore

Virginia Oncology Associates, Norfolk

University of Texas, M.D. Anderson Cancer Center, Houston

University of New Mexico, Albuquerque

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Beth Israel Deaconess Medical Center, Boston